According to the 2016 version of the World Health Organization (WHO) classification of CNS tumors, gliomas can be separated into circumscribed gliomas (WHO Grade I) and diffusely infiltrating gliomas (WHO Grades II–IV) based on their growth pattern and isocitrate dehydrogenase (IDH) mutation status. The gene discussed is IDH3A; the disease is glioma.